Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded in 1992 and is headquartered in London, Canada.
Company profile
Ticker
SEOVF, SVA
Exchange
Website
CEO
Philip M. Toleikis
Employees
Incorporated
Location
Fiscal year end
SEC CIK
SEOVF stock data
Latest filings (excl ownership)
D
$41.51K in equity / options / securities to be acquired, sold $19.16K, 1 investor
6 Oct 20
D
$250.86K in equity / options / securities to be acquired, sold $100.34K, 1 investor
9 Sep 19
D
$25.37K in equity / options / securities to be acquired, sold $10.57K, 1 investor
13 Jul 16
D
$250.5K in equity / options / securities to be acquired, sold $85.08K, 1 investor
5 Apr 12
D
$39.14K in equity / options / securities to be acquired, sold $19.57K, 1 investor
8 Jun 10
D
$49.64K in equity / options / securities to be acquired, sold $29.62K, 1 investor
10 May 10
Latest ownership filings
No filings
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|